Committee on Safety of Medicines
(Redirected from
Committee on the Safety of Medicines
) | This article needs additional citations for verification. (December 2020) |
The Committee on Safety of Medicines (CSM) was an independent advisory committee that advised the UK Licensing Authority on the quality, efficacy, and safety of medicines.
Following the
Department of Health, which reinforced the need for specially trained doctors (clinical pharmacologists) in pharmaceutical companies and academic departments of medicine, Dunlop became the first chairman of the Committee. Under the Medicines Act 1968, the CSD was replaced in 1970 by the Medicines Commission, which established the Committee on Safety of Medicines (CSM) as a Government advisory committee under Section 4 of the Act.[3]
It was replaced on 30 October 2005 by the
Medicines Commission
.
Chairs
- The first chairman of the CSD was Sir Derek Dunlop.[4]
- The first chairman of the CSM was Sir Eric Scowan.[4]
- 1980–1986. Professor Sir Abraham Goldberg
- 1987–1992. Professor Sir William Asscher, previously chair of the Committee on the Review of Medicines[5]
- 1993–1998. Professor Sir Michael Rawlins
- 1999–2005. Professor Sir Alasdair Breckenridge
For later chairs, see Commission on Human Medicines
See also
References
- ^ Tansey, E. M/Yabsley, The Committee On The Safety Of Drugs, A Personal Account, History of Modern Biomedicine Research Group, retrieved 2022-07-25
- ^ Tansey, E; Reynolds, L. "'The Committee on Safety of Drugs'". Wellcome Collection. Retrieved 2022-07-25.
- ^ "History and Aims of the Faculty of Pharmaceutical Medicine". Royal College of Physicians. Archived from the original on 2010-09-20. Retrieved 2010-05-20.
- ^ a b Lesser, Frank (4 December 1980). "How we keep unsafe drugs off the market". New Scientist: 634. Retrieved 10 December 2017.
- Wikidata Q29581621